Home » MailPoet Page
Comments are closed.
December 6th, 2022
Eloxx, a pharmaceutical company, is testing a new treatment that they think might help certain people with Alport Syndrome. Alport syndrome is caused by changes (called mutations) in certain genes. Only
August 18th, 2022
Register now for The 2022 International workshop on Alport Syndrome - Wednesday 7 September 2022On behalf of the Workshop Organising Committee for The 2022 International workshop on Alport Syndrome, we